Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
Clinical trial NCT06300528 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06300528
- Sponsor
- University of Utah
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-03
- Primary completion
- 2026-03-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.